TrialInternational journal of molecular sciences2022

Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer.

Susanne Crocamo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.